[Form 4] Celcuity Inc. Insider Trading Activity
Celcuity Inc. reporting person Lance G. Laing, who serves as Chief Science Officer and a director, received a grant of a stock option covering 100,000 shares of common stock exercisable at $51.57 per share. The option grant is dated 08/18/2025, becomes exercisable on that date, and expires on 08/18/2035.
The filing shows Laing beneficially owns 100,000 shares underlying the option on a direct basis. Vesting terms are disclosed: 25,000 shares vest on 08/18/2026 and the remaining 75,000 vest monthly at a rate of 1/36th thereafter. The Form 4 was signed by an attorney-in-fact on behalf of Laing on 08/20/2025.
Celcuity Inc. 鈥� la persona segnalante Lance G. Laing, Chief Science Officer e membro del consiglio, ha ricevuto un'opzione su 100.000 azioni ordinarie con prezzo di esercizio di $51.57 per azione. L'assegnazione dell'opzione 猫 datata 18/08/2025, diventa esercitabile in tale data e scade il 18/08/2035.
La comunicazione indica che Laing possiede beneficiariamente 100.000 azioni sottostanti l'opzione su base diretta. Le condizioni di maturazione prevedono: 25.000 azioni maturano il 18/08/2026 e le restanti 75.000 maturano mensilmente a un ritmo di 1/36 ciascuna dopo tale data. Il Modulo 4 猫 stato firmato per procura in nome di Laing il 20/08/2025.
Celcuity Inc. 鈥� la persona informante Lance G. Laing, quien se desempe帽a como Chief Science Officer y director, recibi贸 una opci贸n sobre 100.000 acciones ordinarias con precio de ejercicio de $51.57 por acci贸n. La concesi贸n de la opci贸n est谩 fechada el 18/08/2025, es ejercitable en esa fecha y vence el 18/08/2035.
La presentaci贸n indica que Laing posee beneficiariamente 100.000 acciones subyacentes a la opci贸n de forma directa. Los t茅rminos de adjudicaci贸n establecen: 25.000 acciones consolidan el 18/08/2026 y las 75.000 restantes consolidan mensualmente a una tasa de 1/36 a partir de entonces. El Formulario 4 fue firmado por apoderado en representaci贸n de Laing el 20/08/2025.
Celcuity Inc.鞚� 氤搓碃鞛� Lance G. Laing(Chief Science Officer 氚� 鞚挫偓)鞚� 欤茧嫻 頄夓偓 臧�瓴� $51.57搿� 氤错喌欤� 100,000欤检棎 雽�頃� 鞀ろ啞鞓奠厴鞚� 攵�鞐皼鞎橃姷雼堧嫟. 鞓奠厴 攵�鞐澕鞚� 2025/08/18鞚措┌, 霃欖澕 鞚检瀽鞐� 頄夓偓 臧�電ロ暣歆�瓿� 毵岆鞚检潃 2035/08/18鞛呺媹雼�.
鞁犼碃靹滌棎電� Laing鞚� 頃措嫻 鞓奠厴鞐� 旮办磮頃� 100,000欤茧ゼ 歆侅爲鞝�(歆侅爲 氤挫湢)鞙茧 鞁れ 靻岇湢頃橁碃 鞛堧姅 瓴冹溂搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 氩犾姢韺� 臁瓣贝鞚� 雼れ潓瓿� 臧欖姷雼堧嫟: 25,000欤茧姅 2026/08/18鞐� 氩犾姢韸鸽悩瓿�, 雮橂ǜ歆� 75,000欤茧姅 鞚错泟 毵れ洈 1/36 牍勳湪搿� 氩犾姢韸鸽惄雼堧嫟. Form 4電� 2025/08/20鞐� Laing鞚� 雽�毽暅 氤�順胳偓鞐� 鞚橅暣 靹滊獏霅橃棃鞀惦媹雼�.
Celcuity Inc. 鈥� la personne d茅clarante Lance G. Laing, Chief Science Officer et administrateur, a re莽u une option d'achat portant sur 100 000 actions ordinaires au prix d'exercice de 51,57 $ par action. L'attribution est dat茅e du 18/08/2025, devient exer莽able 脿 cette date et expire le 18/08/2035.
Le d茅p么t indique que Laing d茅tient b茅n茅ficiairement 100 000 actions sous-jacentes 脿 l'option de mani猫re directe. Les modalit茅s d'acquisition pr茅cisent : 25 000 actions acquises le 18/08/2026 et les 75 000 restantes s'acqui猫rent ensuite mensuellement au rythme de 1/36. Le formulaire 4 a 茅t茅 sign茅 par un mandataire au nom de Laing le 20/08/2025.
Celcuity Inc. 鈥� die meldende Person Lance G. Laing, Chief Science Officer und Vorstandsmitglied, erhielt eine Aktienoption 眉ber 100.000 Stammaktien mit einem Aus眉bungspreis von $51.57 pro Aktie. Die Optionszuteilung ist auf den 18.08.2025 datiert, wird an diesem Datum aus眉bbar und l盲uft am 18.08.2035 ab.
Die Meldung weist aus, dass Laing wirtschaftlich 100.000 der der Option zugrundeliegenden Aktien direkt besitzt. Die Vesting-Bedingungen lauten: 25.000 Aktien vesten am 18.08.2026, die verbleibenden 75.000 vesten danach monatlich zu je 1/36. Das Formular 4 wurde am 20.08.2025 von einem Bevollm盲chtigten im Namen von Laing unterzeichnet.
- 100,000 share option grant to Chief Science Officer and director Lance G. Laing is disclosed
- Clear vesting schedule: 25,000 shares vest on 08/18/2026 and remaining 75,000 vest monthly thereafter
- None.
Insights
TL;DR: Insider option grant to CSO for 100,000 shares at $51.57; standard multi-year vesting.
The reported grant is a non-derivative option to purchase 100,000 shares at $51.57 with exercisability beginning 08/18/2025 and expiration 08/18/2035. Initial vesting of 25,000 shares occurs one year after grant with the balance vesting monthly thereafter, which aligns executive incentives with multi-year retention. The filing shows direct beneficial ownership of the 100,000 underlying shares following the transaction. This is a routine executive compensation disclosure rather than an operational result; its immediate financial impact on company reporting is limited to disclosure of insider holdings.
TL;DR: Grant reflects customary retention-focused vesting and is disclosed under Section 16 reporting rules.
The Form 4 properly discloses the transaction under Section 16. Vesting schedule鈥攁n initial one-year tranche followed by monthly vesting鈥攊ndicates a retention mechanism commonly used in executive equity awards. The filing was executed by an attorney-in-fact, with signature dated 08/20/2025, satisfying procedural filing formalities. The disclosure does not include additional governance actions or amendments beyond the option grant.
Celcuity Inc. 鈥� la persona segnalante Lance G. Laing, Chief Science Officer e membro del consiglio, ha ricevuto un'opzione su 100.000 azioni ordinarie con prezzo di esercizio di $51.57 per azione. L'assegnazione dell'opzione 猫 datata 18/08/2025, diventa esercitabile in tale data e scade il 18/08/2035.
La comunicazione indica che Laing possiede beneficiariamente 100.000 azioni sottostanti l'opzione su base diretta. Le condizioni di maturazione prevedono: 25.000 azioni maturano il 18/08/2026 e le restanti 75.000 maturano mensilmente a un ritmo di 1/36 ciascuna dopo tale data. Il Modulo 4 猫 stato firmato per procura in nome di Laing il 20/08/2025.
Celcuity Inc. 鈥� la persona informante Lance G. Laing, quien se desempe帽a como Chief Science Officer y director, recibi贸 una opci贸n sobre 100.000 acciones ordinarias con precio de ejercicio de $51.57 por acci贸n. La concesi贸n de la opci贸n est谩 fechada el 18/08/2025, es ejercitable en esa fecha y vence el 18/08/2035.
La presentaci贸n indica que Laing posee beneficiariamente 100.000 acciones subyacentes a la opci贸n de forma directa. Los t茅rminos de adjudicaci贸n establecen: 25.000 acciones consolidan el 18/08/2026 y las 75.000 restantes consolidan mensualmente a una tasa de 1/36 a partir de entonces. El Formulario 4 fue firmado por apoderado en representaci贸n de Laing el 20/08/2025.
Celcuity Inc.鞚� 氤搓碃鞛� Lance G. Laing(Chief Science Officer 氚� 鞚挫偓)鞚� 欤茧嫻 頄夓偓 臧�瓴� $51.57搿� 氤错喌欤� 100,000欤检棎 雽�頃� 鞀ろ啞鞓奠厴鞚� 攵�鞐皼鞎橃姷雼堧嫟. 鞓奠厴 攵�鞐澕鞚� 2025/08/18鞚措┌, 霃欖澕 鞚检瀽鞐� 頄夓偓 臧�電ロ暣歆�瓿� 毵岆鞚检潃 2035/08/18鞛呺媹雼�.
鞁犼碃靹滌棎電� Laing鞚� 頃措嫻 鞓奠厴鞐� 旮办磮頃� 100,000欤茧ゼ 歆侅爲鞝�(歆侅爲 氤挫湢)鞙茧 鞁れ 靻岇湢頃橁碃 鞛堧姅 瓴冹溂搿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 氩犾姢韺� 臁瓣贝鞚� 雼れ潓瓿� 臧欖姷雼堧嫟: 25,000欤茧姅 2026/08/18鞐� 氩犾姢韸鸽悩瓿�, 雮橂ǜ歆� 75,000欤茧姅 鞚错泟 毵れ洈 1/36 牍勳湪搿� 氩犾姢韸鸽惄雼堧嫟. Form 4電� 2025/08/20鞐� Laing鞚� 雽�毽暅 氤�順胳偓鞐� 鞚橅暣 靹滊獏霅橃棃鞀惦媹雼�.
Celcuity Inc. 鈥� la personne d茅clarante Lance G. Laing, Chief Science Officer et administrateur, a re莽u une option d'achat portant sur 100 000 actions ordinaires au prix d'exercice de 51,57 $ par action. L'attribution est dat茅e du 18/08/2025, devient exer莽able 脿 cette date et expire le 18/08/2035.
Le d茅p么t indique que Laing d茅tient b茅n茅ficiairement 100 000 actions sous-jacentes 脿 l'option de mani猫re directe. Les modalit茅s d'acquisition pr茅cisent : 25 000 actions acquises le 18/08/2026 et les 75 000 restantes s'acqui猫rent ensuite mensuellement au rythme de 1/36. Le formulaire 4 a 茅t茅 sign茅 par un mandataire au nom de Laing le 20/08/2025.
Celcuity Inc. 鈥� die meldende Person Lance G. Laing, Chief Science Officer und Vorstandsmitglied, erhielt eine Aktienoption 眉ber 100.000 Stammaktien mit einem Aus眉bungspreis von $51.57 pro Aktie. Die Optionszuteilung ist auf den 18.08.2025 datiert, wird an diesem Datum aus眉bbar und l盲uft am 18.08.2035 ab.
Die Meldung weist aus, dass Laing wirtschaftlich 100.000 der der Option zugrundeliegenden Aktien direkt besitzt. Die Vesting-Bedingungen lauten: 25.000 Aktien vesten am 18.08.2026, die verbleibenden 75.000 vesten danach monatlich zu je 1/36. Das Formular 4 wurde am 20.08.2025 von einem Bevollm盲chtigten im Namen von Laing unterzeichnet.
FAQ
What did Celcuity (CELC) report on the Form 4 filed for Lance G. Laing?
When do the options granted to Lance G. Laing begin to vest?
How many shares does Lance G. Laing beneficially own following the reported transaction?
What is Lance G. Laing's role at Celcuity as stated in the filing?
Who signed the Form 4 and when was it signed?
